[1] WHITING D R, GUARIGUATA L, WEIL C, et al. IDF diabetes atlas:global estimates of the prevalence of diabetes for 2011 and 2030[J]. Diabetes Res Clin Pract, 2011, 94(3): 311-321.
[2] 中华医学会糖尿病学分会.《中国2型糖尿病防治指南(2020版)》[J].中华糖尿病杂志, 2021, 13(4): 317-411.
[3] SANZ-CORBALÁN I, LÁZARO-MARTÍNEZ J L, GARCÍA-ÁLVAREZ Y, et al. Digital deformity assessment prior to percutaneous flexor tenotomy for managing diabetic foot ulcers on the toes[J]. J Foot Ankle Surg, 2019, 58(3): 453-457.
[4] SCHMIDT B M, MUNSON M E, ROTHENBERG G M, et al. Strategies to reduce severe diabetic foot infections and complications during epidemics (STRIDE)[J]. J Diabetes Complications, 2020, 34(11): 107691.
[5] 邵蕊.老年糖尿病足的中西医认识及治疗进展[J]. 天津医科大学学报, 2022, 28(4): 452-455.
[6] 中华医学会糖尿病分会.中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021,37(4): 311-398.
[7] 王芳, 李素梅.经皮氧分压测定在糖尿病足病中的临床应用[J]. 安徽卫生职业技术学院学报, 2010, 9(3): 18-19.
[8] 陈伟, 姜利国, 沙德潜.经皮氧分压在预防及诊治糖尿病足中的作用[J]. 临床诊疗进展, 2018, 32(7): 77-79.
[9] 叶林芳, 郑红英, 巫丽萍.2型糖尿病患者经皮氧分压测定结果观察及影响因素分析[J]. 临床护理杂志, 2016, 15(6): 16-19.
[10] 潘斌斌, 马建华.经皮氧分压测定在糖尿病足和周围动脉病变诊治中的应用[J]. 中国糖尿病杂志, 2013, 21(12): 1142-1143.
[11] 董晓颖, 邓武权, 陆德宾, 等.2型糖尿病患者经皮氧分压与神经传导功能测定的相关性分析[J]. 解放军医学杂志, 2013, 38(1): 39-43.
[12] 彭青.应用经皮氧分压测试检查糖尿病足的研究进展[J].糖尿病新世界, 2017, 20(19): 196-198.
[13] TESFAYE S, SELVARAJAH D. Advances in the epidemiology, pathogenesis, and management of diabetic peripheral neuropathy[J].Diabetes Metab Rev, 2012, 28(Suppl 1): 8-14.
[14] American Diabetes Association. Summary of revisions to the 2011 clinical practice recommendations[J].Diabetes Care, 2011, 34(Suppl 1):S3.
[15] VINCENT A M, CALLAGHAN B C, SMITH A L, et al. Diabetic neuropathy: cellular mechanisms as therapeutic targets[J]. Nat Rev Neurol, 2011, 7(10):573-583.
[16] OWOLABI M O, IPADEOLA A. Total vascular risk as a strong correlate of severity of diabetic peripheral neuropathy in Nigerian Africans[J]. Ethn Dis, 2012, 22(1): 106-112.
[17] 王国凤, 徐宁, 杨涛.经皮氧分压在2型糖尿病周围神经病变中的变化及其临床意义[J].中国糖尿病杂志, 2017, 25(9): 822-826.
[18] BOUHON A J M, VILEIKYTE L, TENNVALL G R, et al. The global burden of diabetic foot disease[J]. Lancet, 2005, 366(9498): 1719-1724.
[19] JIANG Y, RAN X, JIA L, et al.Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China[J]. Int J Low Extrem Wounds, 2015, 14(1):19-27.
[20] 何蕊, 刘芳.糖尿病周围神经病变导致糖尿病足的机制[J]. 中华医学杂志, 2016, 96(32): 2536-2538.
[21] 金星陈, 颖越, 沈赘, 等. 不同方法检测2型糖尿病外周血管疾病差异性比较的观察[J]. 中国糖尿病杂志, 2013, 21(1): 45-47.
[22] 翁焕, 严励.经皮氧分压测定在糖尿病足中的临床应用[J]. 国际内科学杂志, 2008, 35(7): 387-389.
[23] 李艳, 杨郁文.经皮氧分压检查在糖尿病足检查中的应用[J]. 护理研究, 2014, 28(4B): 1374-1375.
[24] FAGLIA E, CLERICI G, CAMINITI M, et al. Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia[J]. Eur J Vasc Endovasc Surg, 2007, 33(6): 73l-736.
[25] POREDOS P, RAKOVEC S, GUZIC S B. Determination of amputation level in ischaemic limbs using TcPO2 measurement[J]. VASA, 2005, 34(2): 108-112.
[26] STRAUSS M B. Hyperbaric oxygen as an intervention for managing wound hypoxia: its role and usefulness in diabetic foot wounds[J]. Foot Ankle Int, 2005, 26(1): 15-18.
[27] ZGONIS T,GARBALOSA J C,BURNS P, et al. A retrospective study of patients with diabetes mellitus after partial foot amputation and hyperbaric oxygen treatment[J]. J Foot Ankle Surg, 2005, 44(4): 276-280.
[28] NIJNIKOSKI J. Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making[J]. Wound Repair Regen, 2003, 11(6):458-461.
[29] CASELLI A, LATINI V, LAPENNA A, et al. Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers[J]. Diabet Med, 2005, 22(4): 460-465.
[30] WAGNER H J, SCHMITZ R, ALFKE H, et al. Influence of precutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease[J]. Radiology, 2003, 226(3): 797-797.
[31] ARROYO C I, TRITTO V G, BUCHBINDER D, et al. Optimal waiting period for foot salvage surgery following limb revascularization[J]. J Foot Ankle Surg, 2002, 41(4): 228-232.
[32] PEDRINI L, MAGNONI F. Spinal cord stimulation for lower limb ischemic pain treatment[J].Interact Cardiovasc Thorac Surg, 2007, 6(4): 495-500.
[33] HORSCH S, SCHULTE S, HESS S. Spinal cord stimulation in the treatment of peripheral vascular disease: results of a single center study of 258 patients[J]. Angiology, 2004, 55(2): 111-118.
[34] UBBINK D T, GERSBACH P A, BERG P, et al.The best TcPO2 parameters to predict the efficacy of spinal cord stimulation to improve limb salvage in patients with inoperable critical leg ischemia[J]. Int Angiol, 2003, 22(4): 356-363.
[35] KALANI M, SILVEIRA A, BLOMBACK M, et al. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers[J]. Thromb Res, 2007, 120(5): 653-661.
[36] MELILLO E, FERRARI M, BALBARINI A, et al. Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia[J]. Vasc Endovascular Surg, 2006, 40(4): 303-311. |
